US 12351834
Compositions and methods for the treatment of ornithine transcarbamylase deficiency
granted A61KA61K2039/51A61K31/221
Quick answer
US patent 12351834 (Compositions and methods for the treatment of ornithine transcarbamylase deficiency) held by ARCTURUS THERAPEUTICS, INC. expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARCTURUS THERAPEUTICS, INC.
- Grant date
- Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K2039/51, A61K31/221, A61K48/00, A61K48/0033